Immunome (IMNM) Assets Average (2023 - 2025)
Historic Assets Average for Immunome (IMNM) over the last 3 years, with Q3 2025 value amounting to $297.8 million.
- Immunome's Assets Average rose 769.35% to $297.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $297.8 million, marking a year-over-year increase of 769.35%. This contributed to the annual value of $194.4 million for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2025, Immunome's Assets Average is $297.8 million, which was up 769.35% from $319.5 million recorded in Q2 2025.
- In the past 5 years, Immunome's Assets Average registered a high of $319.5 million during Q2 2025, and its lowest value of $44.8 million during Q2 2023.
- For the 3-year period, Immunome's Assets Average averaged around $220.9 million, with its median value being $262.6 million (2024).
- In the last 5 years, Immunome's Assets Average surged by 58785.69% in 2024 and then soared by 373.62% in 2025.
- Over the past 3 years, Immunome's Assets Average (Quarter) stood at $120.9 million in 2023, then surged by 105.68% to $248.6 million in 2024, then rose by 19.82% to $297.8 million in 2025.
- Its last three reported values are $297.8 million in Q3 2025, $319.5 million for Q2 2025, and $291.5 million during Q1 2025.